跳至主要内容
临床试验/NCT00743262
NCT00743262已完成1 期

Second Amendment on Phase I Trial NO7VEG 'Assessment of a Next Generation Indwelling Provox Voice Rehabilitation System (Vega)': Vega Siri Addendum.

Atos Medical AB1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2008年4月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
15
试验地点
1
主要终点
Short-term Feasibility Provox Vega 22.5 French

研究概览

简要总结

The purpose of this study is to investigate the performance of a new voice prosthesis in comparison with the Provox2 and the Provox ActiValve voice prosthesis in 15 laryngectomized patients. Factors taken into account are clinician and patient satisfaction with the insertion system, patient satisfaction with voice, speech, performance, and maintenance. Voice and speech will also be evaluated for the different prostheses by means of perceptual evaluations and acoustic analysis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Total laryngectomy
  • •Use Provox ActiValve

排除标准

  • •Current problems with TE puncture

研究组 & 干预措施

Provox voice prosthesis

Experimental

干预措施: Provox voice prosthesis (Device)

结局指标

主要结局

Short-term Feasibility Provox Vega 22.5 French

时间窗: 3 weeks

Number of participants in whom the voice prosthesis was considered feasible in the short-term with regards to clinical and technical aspects as judged by patient and investigator.

次要结局

  • Device Life Time(one year)
  • Subjective Voice and Speech Quality(3 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验